Opinion

Video

Testing for MRD in Colorectal Cancer

Author(s):

John L. Marshall, MD,Benjamin Weinberg, MD

Focusing on the adjuvant setting, the expert panel discusses the timing and frequency of MRD testing in patients with colorectal cancer.

Related Videos
Aasma Shaukat, MD, MPH, discusses the sensitivity of the PREEMPT CRC blood-based assay in detecting colorectal cancer for patients at average risk.
Related Content
Organ Preservation Decisions in Rectal Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
January 27th 2025

Post-Chemotherapy ctDNA Status May Support Organ Preservation Decisions in Rectal Cancer

Ryan Cassaday, MD, associate professor, Clinical Research Division, Fred Hutchinson Cancer Center; associate professor, Division of Hematology and Oncology, University of Washington School of Medicine
January 23rd 2025

Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD

CRC | Image Credit: © Anatomy Insider – stock.adobe.com
January 27th 2025

Fruquintinib Plus TAS-102 Demonstrates Efficacy and Acceptable Toxicity in Pretreated mCRC

Mazyar Shadman, MD, MPH, associate professor, Clinical Research Division, medical director, Cellular Immunotherapy, Fred Hutchinson Cancer Center
December 19th 2024

Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

Gastrointestinal Cancer | Image Credit: © Crystal light – stock.adobe.com
January 27th 2025

Revisit the Top Presentations and Biggest Data From the 2025 Gastrointestinal Cancers Symposium

CRC | © Sebastian Kaulitzki – stock.adobe.com
January 26th 2025

Signatera ctDNA Assay Found to Influence Adjuvant Chemo Decision-Making in Stage II/III CRC